Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.45
Delayed Data
As of May 26
 +0.0065 / +1.47%
Today’s Change
0.26
Today|||52-Week Range
1.16
-29.41%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.44
Today’s open0.44
Day’s range0.44 - 0.46
Volume310,614
Average volume (3 months)818,946
Market cap$72.9M
Dividend yield--
Data as of 4:02pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+111.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+65.82%
P/E ratioNM
Price/Sales4.51
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.02+1.85%
XENEXenon Pharmaceutical...+0.05+1.27%
SPHSSophiris Bio Inc-0.01-0.40%
SYNSynthetic Biologics ...+0.01+2.50%
Data as of 4:02pm ET, 05/26/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$22.0M
Annual profit (last year)-$14.3M
Net profit margin-65.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts